Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBT Margin (2020 - 2025)

Stemtech's EBT Margin history spans 5 years, with the latest figure at 95.34% for Q3 2025.

  • For Q3 2025, EBT Margin rose 1821.0% year-over-year to 95.34%; the TTM value through Sep 2025 reached 79.43%, up 2329.0%, while the annual FY2024 figure was 74.65%, 3572.0% up from the prior year.
  • EBT Margin for Q3 2025 was 95.34% at Stemtech, down from 42.45% in the prior quarter.
  • Across five years, EBT Margin topped out at 1660.53% in Q3 2022 and bottomed at 1956.08% in Q2 2022.
  • The 5-year median for EBT Margin is 75.39% (2021), against an average of 114.46%.
  • The largest YoY upside for EBT Margin was 224649bps in 2022 against a maximum downside of -188069bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 64.62% in 2021, then soared by 36bps to 41.32% in 2022, then plummeted by -231bps to 136.88% in 2023, then soared by 78bps to 30.19% in 2024, then tumbled by -216bps to 95.34% in 2025.
  • Per Business Quant, the three most recent readings for STEK's EBT Margin are 95.34% (Q3 2025), 42.45% (Q2 2025), and 168.05% (Q1 2025).